Press-release for stocks for JNJ

Sort by: gain open | gain high | gain close | publishing date

symbols : JNJ

save search

Premia Spine Appoints Three New Board Advisors
Published: 2021-12-08 (Crawled : 13:30) - biospace.com/
JNJ | News | $164.34 |

Health Technology

| 0.29% | O: -0.24% H: 0.67% C: 0.53%
spine

2021 Digital Transformation Market Report by Application & Service, Use Case and Industry Vertical Forecasts to 2026
Published: 2021-12-08 (Crawled : 12:30) - prnewswire.com
TCLRY | News | $0.0979 |

Manufacturing

| 10.0% | O: 1.24% H: 8.77% C: 8.66%
KDDIY | News | $14.67 |

Information

| -0.88% | O: 0.0% H: 0.95% C: -0.88%
WHR | News | $227.95 |

Consumer Durables

| -1.26% | O: -0.09% H: 0.45% C: -1.17%
SNAP | News | $53.42 |

Technology Services

| 7.96% | O: 2.3% H: 8.33% C: 5.53%
JNPR | News | $32.43 |

Technology Services

| 0.86% | O: 1.69% H: 1.22% C: -0.83%
HAS | News | $100.93 |

Consumer Durables

| 1.19% | O: 0.66% H: 0.78% C: 0.53%
ERIC | News | $10.39 |

Electronic Technology

| 0.82% | O: 0.82% H: 0.0% C: 0.0%
GAHC | News | $0.0015 |

Transportation and Warehousing

| -11.76% | O: 0.0% H: 5.88% C: -11.76%
NOK | News | $5.86 |

Electronic Technology

| 2.72% | O: 3.24% H: 0.68% C: -0.51%
MDT | News | $112.42 |

Health Technology

| 0.56% | O: 0.53% H: 0.46% C: 0.04%
MCK | News | $226.68 |

Distribution Services

| 0.98% | O: 1.8% H: 1.59% C: -0.8%
POOL | News | $564.77 |

Distribution Services

| 1.74% | O: 1.51% H: 0.45% C: 0.23%
CHKP | News | $110.89 |

Technology Services

| -2.21% | O: -2.28% H: 0.83% C: 0.07%
NOKBF | News | $5.944 |

Electronic Technology

| 0.78% | O: -2.63% H: 3.5% C: 3.5%
ZTCOY | News | $5.19 |

Manufacturing

| 1.37% | O: -1.76% H: 3.38% C: 3.18%
PLTR | News | $19.82 |

Technology Services

| 3.23% | O: 1.61% H: 1.61% C: 1.59%
JNJ | News | $164.34 |

Health Technology

| 0.29% | O: -0.24% H: 0.67% C: 0.53%
T | News | $23.17 |

Communications

| -0.52% | O: -1.16% H: 2.37% C: 0.65%
IRBT | News | $75.95 |

Consumer Durables

| 3.29% | O: -0.41% H: 4.11% C: 3.71%
ORCL | News | $88.94 |

Technology Services

| -1.17% | O: 0.07% H: 0.13% C: -1.23%
NOC | News | $364.09 |

Electronic Technology

| -0.43% | O: -0.59% H: 1.04% C: 0.15%
KT | News | $13.08 |

Communications

| 0.38% | O: -0.15% H: 0.77% C: 0.54%
DELL | News | $58.4 |

Electronic Technology

| -1.33% | O: -0.37% H: 0.0% C: 0.0%
CIEN | News | $62.2 |

Electronic Technology

| -0.03% | O: 1.0% H: 0.49% C: -1.02%
ZIXI | News | $8.49 |

Technology Services

| -0.06% | O: -0.18% H: 0.12% C: 0.12%
VUZI | News | $10.39 |

Electronic Technology

| 3.74% | O: 2.45% H: 3.51% C: 1.27%
NXPI | News | $228.09 |

Electronic Technology

| -0.44% | O: -0.04% H: 0.34% C: -0.4%
NVDA | News | $318.26 |

Electronic Technology

| 2.81% | O: 3.37% H: 0.91% C: -0.54%
MSFT | News | $334.97 |

Technology Services

| 0.97% | O: 1.07% H: 0.06% C: -0.1%
application

Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy Card
Published: 2021-12-07 (Crawled : 14:30) - biospace.com/
SCPS | $2.18 |

| 6.86% | O: 6.86% H: 5.5% C: -0.92%
JNJ | News | $164.34 |

Health Technology

| 2.42% | O: 2.13% H: 0.0% C: 0.0%
biopharma

Janssen Announces Respiratory Syncytial Virus (RSV) Adult Vaccine Candidate Maintains High Efficacy Regardless of Lower Respiratory Tract Disease Severity
Published: 2021-12-07 (Crawled : 14:30) - biospace.com/
JNJ | News | $164.34 |

Health Technology

| 2.42% | O: 2.13% H: 0.0% C: 0.0%
respiratory disease vaccine

Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Published: 2021-12-07 (Crawled : 14:00) - prnewswire.com
RDHL | $3.19 |

Health Technology

| 18.59% | O: 0.37% H: 10.37% C: 9.63%
GLAXF | News | $20.5305 |

Health Technology

| 2.04% | O: 5.22% H: 0.0% C: -1.25%
SRNE | $6.29 |

Health Technology

| 25.3% | O: 6.57% H: 14.77% C: 11.21%
JNJ | News | $164.34 |

Health Technology

| 2.42% | O: 2.13% H: 0.0% C: 0.0%
GSK | News | $42.68 |

Health Technology

| 1.93% | O: 0.14% H: 0.0% C: 0.0%
VIR | $41.89 |

Health Technology

| -1.09% | O: -6.42% H: 8.6% C: 8.45%
covid vaccine

Global Interventional Oncology Devices Market Report 2021: Financial Burden of Product Recalls & Lack of Clinical Evidence for Locoregional Treatments - Major Market Challenges
Published: 2021-12-07 (Crawled : 12:30) - prnewswire.com
TRUMY | News | $43.05 |

Manufacturing

| 5.31% | O: 1.42% H: 0.96% C: 0.96%
TRUMF | News | $42.382 |

Health Technology

| 4.06% | O: 4.89% H: 0.0% C: -3.96%
MDT | News | $112.42 |

Health Technology

| 4.31% | O: 3.72% H: 0.0% C: 0.0%
BDX | News | $246.45 |

Health Technology

| 0.35% | O: 0.66% H: 2.21% C: 1.27%
MMSI | $66.23 |

Health Technology

| 5.43% | O: 5.09% H: 2.79% C: 0.83%
JNJ | News | $164.34 |

Health Technology

| 2.42% | O: 2.13% H: 0.0% C: 0.0%
BSX | News | $41.66 |

Health Technology

| 4.58% | O: 3.53% H: 1.99% C: 0.39%
ANGO | $26.48 |

Health Technology

| 4.01% | O: 3.42% H: 2.58% C: 0.61%
ICCM | $4.28 |

Manufacturing

| -2.73% | O: -0.68% H: 5.95% C: 5.26%
treatment device

Needle-Free Injections Market is Growing at a CAGR of 14.15% during the Forecast Period from 2021 to 2026 and will reach USD 24.12 billion by 2026, Affirms DelveInsight
Published: 2021-12-06 (Crawled : 17:00) - prnewswire.com
TRUMF | News | $42.382 |

Health Technology

| 2.23% | O: 0.5% H: 0.19% C: -2.25%
TRUMY | News | $43.05 |

Manufacturing

| 5.57% | O: 0.12% H: 0.2% C: 0.12%
NVO | $113.41 |

Health Technology

| 5.91% | O: 1.0% H: 0.0% C: 0.0%
WST | $435.51 |

Health Technology

| -1.3% | O: -1.59% H: 0.0% C: 0.0%
LLY | $244.32 |

Health Technology

| -2.99% | O: -2.2% H: 0.0% C: 0.0%
ABBV | $121.87 |

Health Technology

| 3.45% | O: 1.57% H: 0.0% C: 0.0%
JNJ | News | $164.34 |

Health Technology

| 3.94% | O: 1.49% H: 0.0% C: 0.0%
injection growing

COVID-19: Omicron May be Mild; J&J Data Support Mix & Match Boosting
Published: 2021-12-06 (Crawled : 16:00) - biospace.com/
JNJ | News | $164.34 |

Health Technology

| 3.94% | O: 1.49% H: 0.0% C: 0.0%
covid

Bsense Announces Positive Topline Proof-of-Concept Preclinical Data that Supports the Development in Additional Sensory Hyperexcitability Related Disorders
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
JNJ | News | $164.34 |

Health Technology

| 3.94% | O: 1.49% H: 0.0% C: 0.0%
sensor order preclinical positive topline

AnHeart Therapeutics Appoints Hua Zheng, M.D, Ph.D, as SVP, Head of Global Regulatory Affairs
Published: 2021-12-06 (Crawled : 14:00) - biospace.com/
JNJ | News | $164.34 |

Health Technology

| 3.94% | O: 1.49% H: 0.0% C: 0.0%
heart era therapeutics

Avicanna Files a Patent to Protect its Advanced Oral Cannabinoid Platform and its Applications for Neurological Diseases
Published: 2021-12-06 (Crawled : 13:00) - globenewswire.com
JNJ | News | $164.34 |

Health Technology

| 3.94% | O: 1.49% H: 0.0% C: 0.0%
neurological application patent disease platform

Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening its Capital Base
Published: 2021-12-06 (Crawled : 07:00) - globenewswire.com
JNJ | News | $164.34 |

Health Technology

| 3.94% | O: 1.49% H: 0.0% C: 0.0%
trial vaccine phase 3

Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses
Published: 2021-12-05 (Crawled : 00:00) - prnewswire.com
JNJ | News | $164.34 |

Health Technology

| 3.94% | O: 1.49% H: 0.0% C: 0.0%
covid antibody t-cell

Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
Published: 2021-12-05 (Crawled : 20:20) - globenewswire.com
JNJ | News | $164.34 |

Health Technology

phase 2 covid positive phase 2 results results topline vaccine

Lilly's bamlanivimab with etesevimab authorized as the first and only neutralizing antibody therapy for emergency use in COVID-19 patients under the age of 12
Published: 2021-12-03 (Crawled : 20:00) - prnewswire.com
LLY | $244.32 |

Health Technology

JNJ | News | $164.34 |

Health Technology

era covid therapy authorized antibody merge

Bayer Looks to Prostate Cancer Drug for Next Blockbuster
Published: 2021-12-03 (Crawled : 20:00) - biospace.com/
JNJ | News | $164.34 |

Health Technology

| 4.23% | O: 0.28% H: 0.0% C: 0.0%
prostate cancer drug cancer drug cancer

"Fourth Wave" Driven Primarily by Delta and New Omicron Data
Published: 2021-12-03 (Crawled : 18:00) - biospace.com/
JNJ | News | $164.34 |

Health Technology

| 4.23% | O: 0.28% H: 0.0% C: 0.0%

Bayer Looks to Prostate Cancer Drug as Next Blockbuster
Published: 2021-12-03 (Crawled : 17:00) - biospace.com/
JNJ | News | $164.34 |

Health Technology

| 4.23% | O: 0.28% H: 0.0% C: 0.0%
prostate cancer drug cancer drug cancer

The Ad Council's 67th Annual Public Service Award Dinner Celebrates Extraordinary Accomplishments and Inspires a Future That is Better Together
Published: 2021-12-03 (Crawled : 17:00) - prnewswire.com
JNJ | News | $164.34 |

Health Technology

| 4.23% | O: 0.28% H: 0.0% C: 0.0%

BioSpace Movers & Shakers, Dec. 3
Published: 2021-12-03 (Crawled : 17:00) - biospace.com/
JNJ | News | $164.34 |

Health Technology

| 4.23% | O: 0.28% H: 0.0% C: 0.0%
LLY | $244.32 |

Health Technology

| -0.91% | O: 2.15% H: 0.0% C: 0.0%
PODD | News | $277.13 |

Health Technology

| -3.52% | O: 0.81% H: 1.09% C: -9.12%
DERM new | $6.85 |

| 1.48% | O: 0.04% H: 3.37% C: -0.04%
IART | $65.91 |

Health Technology

| 3.55% | O: 0.2% H: 0.34% C: -1.71%
MS | News | $102.77 |

Finance

| 6.82% | O: 3.91% H: 0.0% C: 0.0%
SNY | News | $47.99 |

Health Technology

| 0.15% | O: -0.96% H: 0.0% C: 0.0%
ORIC | $15.11 |

Health Technology

| 10.13% | O: 1.53% H: 2.58% C: 1.29%
space spac

← Previous
1
2
3
4
5
6
7
8
9
…
71
72
Next →

symbols : JNJ

save search

Your saved searches

Mentioned Today

symbols : JNJ save search

Your saved searches

Mentioned Today

symbols : JNJ

save search